e-learning
resources
Glasgow 2004
Monday 06.09.2004
Emphysema and oxygen therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long term oxygen therapy: analysis of factors related to prevalence variability
A. León, J. L. López-Campos, L. Olea, B. Jurado, A. Arnedillo, S. Cano, F. Casas, L. Muñoz, S. López (Cádiz, Seville, Córdoba, Granada, Spain)
Source:
Annual Congress 2004 - Emphysema and oxygen therapy
Session:
Emphysema and oxygen therapy
Session type:
Oral Presentation
Number:
1513
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. León, J. L. López-Campos, L. Olea, B. Jurado, A. Arnedillo, S. Cano, F. Casas, L. Muñoz, S. López (Cádiz, Seville, Córdoba, Granada, Spain). Long term oxygen therapy: analysis of factors related to prevalence variability. Eur Respir J 2004; 24: Suppl. 48, 1513
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Home long term oxygen therapy (LTOT): analysis of an high degree of complexity service and impact on hospitalization
Source: Annual Congress 2007 - Programmes and management in pulmonary rehabilitation
Year: 2007
Long term oxygen therapy: compliance and disability among patients
Source: Eur Respir J 2002; 20: Suppl. 38, 256s
Year: 2002
Influence of the geographical height in the prevalence of long term oxygen therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 301s
Year: 2002
Patient‘s perceptions of use of long term oxygen therapy
Source: Annual Congress 2008 - Quality of life and mood disturbances in rehabilitation
Year: 2008
Long term oxygen therapy in children
Source: Online Course 2012 - Oxygen therapy
Year: 2012
Long term oxygen therapy: a regional survey of physician attitudes towards controversial aspects
Source: Annual Congress 2004 - Emphysema and oxygen therapy
Year: 2004
The COVID-19 risk perception and concern: a survey of patients on long term oxygen therapy or domiciliary noninvasive ventilation
Source: Virtual Congress 2021 – E-health for COVID-19
Year: 2021
The association of the oxygen saturation level at the time of hospitalization with comorbidities and subsequent changes in blood biomarkers in patients with COVID-19 in Russia: observational study results.
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021
Oxygen assessment services can significantly rationalise long term oxygen therapy (LTOT) and reduce costs
Source: Annual Congress 2009 - Nursing challenges at home and in hospital
Year: 2009
Long term oxygen therapy in COPD
Source: Online Course 2012 - Oxygen therapy
Year: 2012
Long term oxygen therapy (LTOT) in the real world: findings of home visiting
Source: Annual Congress 2009 - Nursing challenges at home and in hospital
Year: 2009
Air travel in patients on long term oxygen therapy: Lying low or flying high?
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016
Psychosocial adjustment profile is related to functional status at long term in COPD patients
Source: International Congress 2019 – Insights into assessment of functional status in respiratory disease patients
Year: 2019
Severe COVID-19 patients : predictive factors for high oxygen requirement
Source: Virtual Congress 2021 – COVID - 19
Year: 2021
Usefulness and impact of an educational programme (EP) on long term oxygen therapy (LTOT) prescriptions
Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients
Year: 2009
Long term outcome of PAH therapy - the past and the future
Source: Annual Congress 2008 - Current and future pulmonary arterial hypertension combination therapy
Year: 2008
Participation in the ARGA study: Long term impact on asthma management
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012
Prediction of circadian changes in time domain (TD) heart rate variability (HRV); use of short term HRV monitoring
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Smoking habits and long term oxygen therapy
Source: Annual Congress 2008 - The biology of smoking and COPD
Year: 2008
Relationship between prior triple therapy use and benefits of budesonide/glycopyrronium/formoterol on exacerbation risk: analysis from ETHOS
Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept